Tinea capitis
233 Tinea capitis Elisabeth M. Higgins Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Tinea capitis (scalp…
Drug eruptions
62 Drug eruptions Neil H. Shear and Sandra R. Knowles Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case…
Dissecting cellulitis of the scalp
61 Dissecting cellulitis of the scalp Andrew J.G. McDonagh Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports…
Sporotrichosis
221 Sporotrichosis Mahreen Ameen and Wanda Sonia Robles Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Sporotrichosis…
Paracoccidioidomycosis (South American blastomycosis)
172 Paracoccidioidomycosis (South American blastomycosis) Wanda Sonia Robles and Mahreen Ameen Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal…
Transient acantholytic dermatosis (Grover disease)
238 Transient acantholytic dermatosis (Grover disease) Murtaza Khan and John Berth-Jones Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal…
Tuberculosis and tuberculids
240 Tuberculosis and tuberculids Yasaman Mansouri and John Berth-Jones Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports…
Livedo reticularis
134 Livedo reticularis Ruwani P. Katugampola and Andrew Y. Finlay Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case…
Granulomatous cheilitis
94 Granulomatous cheilitis Charlene Lam and Bryan E. Anderson Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports…
